MAS
47
-4
UA
50
-4
MTCH
53
-2
HCP
72
-2
EXPE
69
2
TSCO
51
-4
JBHT
40
-3
USB
42
-4
ADT
50
-3
NKE
42
-3
ED
30
-3
AAL
32
3
AFL
62
-2
PLD
61
-3
BF.B
48
-5
FCX
47
-2
GPC
43
5
ESS
70
-4
NTAP
67
2
BRK.B
40
-2
MAS
47
-4
UA
50
-4
MTCH
53
-2
HCP
72
-2
EXPE
69
2
TSCO
51
-4
JBHT
40
-3
USB
42
-4
ADT
50
-3
NKE
42
-3
ED
30
-3
AAL
32
3
AFL
62
-2
PLD
61
-3
BF.B
48
-5
FCX
47
-2
GPC
43
5
ESS
70
-4
NTAP
67
2
BRK.B
40
-2
Financhill
Back

New York Community Bancorp Vs. Keros Therapeutics Industry Stock Comparison

Sell
33

NYCB
New York Community Bancorp

Last Price:
3.03
Seasonality Move:
2.81%
Sell
25

KROS
Keros Therapeutics

Last Price:
45.02
Seasonality Move:
4.22%
Sell
33
New York Community Bancorp (NYCB) is a Sell

Is New York Community Bancorp a Buy, Sell or Hold?

  • The current New York Community Bancorp [NYCB] share price is $2.99. The Score for NYCB is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NYCB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NYCB Stock Price Chart

What is New York Community Bancorp's stock price today?

  • The New York Community Bancorp share price today is $2.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NYCB is experiencing selling pressure, which indicates risk of future bearish movement.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

NYCB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 40.54 Sell
Chaikin Money Flow: -8768397 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.08 - 3.34) Sell
Bollinger Bands (100): (2.91 - 4.27) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.91 Sell
Relative Strength Index (14 RSI): 36.74 Sell
Chaikin Money Flow: -120480 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.18 - 50.06) Sell
Bollinger Bands (100): (50.42 - 64.92) Sell

NYCB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.08 Sell
20-day SMA: 3.16 Sell
50-day SMA: 3.25 Sell
200-day SMA: 6.92 Sell
8-day EMA: 3.08 Sell
20-day EMA: 3.17 Sell
50-day EMA: 3.4 Sell
200-day EMA: 6 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Sell
20-day SMA: 47.57 Sell
50-day SMA: 52.43 Sell
200-day SMA: 46.94 Sell
8-day EMA: 46.46 Sell
20-day EMA: 48 Sell
50-day EMA: 51.59 Sell
200-day EMA: 50.14 Sell

New York Community Bancorp Earnings Growth & NYCB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.41 per share, an increase next quarter of $0.12 per share, a decrease this year of $1.82 per share, and an increase next year of $0.77 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

New York Community Bancorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):